Furukawa M, Takimoto T, Morishita K, Komori T, Ishiguro H, Umeda R
Auris Nasus Larynx. 1983;10(1):43-8. doi: 10.1016/s0385-8146(83)80027-3.
Since antibody titers against Epstein-Barr virus (EBV) antigens are often elevated in sera of patient with active undifferentiated and nonkeratinizing nasopharyngeal carcinoma, anti-EBV serologic tests have been applied for diagnosis of metastatic lymphadenopathy in the neck without an obvious source and/or suspicious tumor of the nasopharynx. In this study it is emphasized that the serologic test procedure was helpful in diagnosing a patient with nasopharyngeal carcinoma that was initially occult but eventually confirmed by biopsy.